GoodRx Holdings, Inc.
Case Overview
34 Days Left to Seek Lead Plaintiff
Lead Plaintiff Deadline: | Lead Plaintiff Deadline: 06/21/2024 |
Status: | Status: Investigating |
Company Name: | Company Name: GoodRx Holdings, Inc. |
Court: | Court: Central District of California |
Case Number: | Case Number: 2:24cv03282 |
Class Period: | Class Period: 09/23/2020 - 11/08/2022 |
Ticker: | Ticker: GDRX |
Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired GoodRX Holdings, Inc. (“GoodRX” or the “Company”) (NASDAW: GDRX) securities during the period of September 23, 2020 through November 8, 2022, inclusive (“the Class Period”). Investors have until June 21, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
The lawsuit alleges that GoodRx made false statements and/or concealed that: (1) while Kroger accounted for less than 5% of the pharmacies accepting GoodRx discounts, Kroger was responsible for nearly 25% of GoodRx's total prescription transactions revenue (the Company's primary revenue stream); and (2) Kroger could unilaterally cease accepting GoodRx discounts, cutting off some or all of GoodRx's revenues for purchases at Kroger's pharmacies.
The lawsuit alleges that GoodRx made false statements and/or concealed that: (1) while Kroger accounted for less than 5% of the pharmacies accepting GoodRx discounts, Kroger was responsible for nearly 25% of GoodRx's total prescription transactions revenue (the Company's primary revenue stream); and (2) Kroger could unilaterally cease accepting GoodRx discounts, cutting off some or all of GoodRx's revenues for purchases at Kroger's pharmacies.